BIO Will Build “World Class Advocacy Organization” Under Greenwood
Executive Summary
The Biotechnology Industry Organization will be working to ensure that the concerns about drug safety do not delay product approvals as a first priority under President James Greenwood
You may also be interested in...
BIO Health Section oversight
Biotechnology Industry Organization forms a new Health Section Governing Body Jan. 3. Restructuring decentralizes responsibility for executing and ratifying healthcare-related policy decisions away from BIO's Board of Directors and executive committee to the Health Section Governing Body. Health Section is the fourth section to have a governing body, completing a shift in organizational structure that began with the arrival of CEO Jim Greenwood one year ago (1"The Pink Sheet" Jan. 10, 2005, p. 13). The Governing Body will initially be composed of 40 members of the current board and will remain as such until elections are held during BIO's annual meeting in April...
BIO Health Section oversight
Biotechnology Industry Organization forms a new Health Section Governing Body Jan. 3. Restructuring decentralizes responsibility for executing and ratifying healthcare-related policy decisions away from BIO's Board of Directors and executive committee to the Health Section Governing Body. Health Section is the fourth section to have a governing body, completing a shift in organizational structure that began with the arrival of CEO Jim Greenwood one year ago (1"The Pink Sheet" Jan. 10, 2005, p. 13). The Governing Body will initially be composed of 40 members of the current board and will remain as such until elections are held during BIO's annual meeting in April...
BIO Fills Top Executive Posts, Including Government Relations VP
The Biotechnology Industry Organization completed its reorganization under new President Jim Greenwood by formally naming five top executives April 28